TickerFacts.

Immucell Corp (ICCC): Cost of Revenue

Annual figures by period end, from SEC filings.

$16.20M
Year ended 2025-12-31
$18.31M
Trailing 12 months to 2026-06-30
+14.1%
3-year compound annual growth
+13.8%
5-year compound annual growth
+15.1%
10-year compound annual growth
$18.55M2009-12-31: $2.11M2010-12-31: $2.08M2011-12-31: $2.30M2012-12-31: $2.34M2013-12-31: $2.95M2014-12-31: $3.15M2015-12-31: $3.98M2016-12-31: $4.12M2017-12-31: $5.21M2018-12-31: $5.79M2019-12-31: $6.98M2020-12-31: $8.48M2021-12-31: $10.59M2022-12-31: $10.92M2023-12-31: $13.60M2024-12-31: $18.55M2025-12-31: $16.20M$16.20M
2009-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$16.20M-12.7%2026-03-30, From 2025-01-01
2024-12-31$18.55M+36.4%2026-03-30, From 2024-01-01
2023-12-31$13.60M+24.6%2025-03-28, From 2023-01-01
2022-12-31$10.92M+3.1%2024-04-01, From 2022-01-01
2021-12-31$10.59M+24.9%2023-03-29, From 2021-01-01
2020-12-31$8.48M+21.4%2022-03-30, From 2020-01-01
2019-12-31$6.98M+20.6%2021-03-30, From 2019-01-01
2018-12-31$5.79M+11.2%2020-03-27, From 2018-01-01
2017-12-31$5.21M+26.3%2019-03-22, From 2017-01-01
2016-12-31$4.12M+3.7%2018-03-29, From 2016-01-01
2015-12-31$3.98M+26.4%2017-03-30, From 2015-01-01
2014-12-31$3.15M+6.8%2016-03-25, From 2014-01-01
2013-12-31$2.95M+26.2%2016-03-25, From 2013-01-01
2012-12-31$2.34M+1.7%2015-03-26, From 2012-01-01
2011-12-31$2.30M+10.3%2014-03-26, From 2011-01-01
2010-12-31$2.08M-1.1%2013-03-28, From 2010-01-01
2009-12-31$2.11Mn/a2012-03-27, From 2009-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Immucell Corp (ICCC)2025-12-31$16.20M-12.7%
Alpha Teknova, Inc. (TKNO)2025-12-31$27.08M-11.3%
Aspira Women's Health Inc. (AWHL)2025-12-31$3.30M-10.9%
Anbio Biotechnology (NNNN)2025-12-31$1.10M-52.0%
Biomerica Inc (BMRA)2026-05-31$4.09M-15.0%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$1.75M+66.2%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$200.0K0.0%
Myriad Genetics Inc (MYGN)2025-12-31$247.90M-1.7%
Neogen Corp (NEOG)2026-05-31$461.90M-2.4%

Compare ICCC, TKNO, AWHL, NNNN side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗